MicroRNA‐508 suppresses epithelial‐mesenchymal transition, migration, and invasion of ovarian cancer cells through the MAPK1/ERK signaling pathway
Author:
Affiliation:
1. Department of Gynecology and ObstetricsZhujiang Hospital of Southern Medical UniversityGuangzhouP. R. China
2. Department of GynecologyHainan General HospitalHaikouP. R. China
3. Department of RadiologyHainan General HospitalHaikouP. R. China
Funder
Hainan Key Science and Technology Project
Hainan Natural Science Foundation-funded project
Hainan Health Department research project approval
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27052
Reference35 articles.
1. Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer Progression
2. Ovarian cancer immunotherapy: opportunities, progresses and challenges
3. PET/CT scanning guided intensity-modulated radiotherapy in treatment of recurrent ovarian cancer
4. Notch3 induces epithelial–mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells
5. Epithelial–mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis and Characterization of Novel Indazole–Sulfonamide Compounds with Potential MAPK1 Inhibitory Activity for Cancer Treatment;Molbank;2024-07-26
2. Preclinical efficacy of CBR-5884 against epithelial ovarian cancer cells by targeting the serine synthesis pathway;Discover Oncology;2024-05-11
3. Drug resistance in ovarian cancer: from mechanism to clinical trial;Molecular Cancer;2024-03-28
4. The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications;International Review of Cell and Molecular Biology;2024
5. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies;Signal Transduction and Targeted Therapy;2023-12-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3